Results 21 to 30 of about 1,281,004 (254)

Artificial Intelligence in Cardiovascular Medicine: Current Insights and Future Prospects

open access: yesVascular Health and Risk Management, 2022
Ikram U Haq,1 Karanjot Chhatwal,2 Krishna Sanaka,3 Bo Xu4 1Department of Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA; 2Imperial College London School of Medicine, London, SW7 2AZ, UK; 3Emory University, Atlanta, GA, 30322, USA; 4Section of ...
Haq IU, Chhatwal K, Sanaka K, Xu B
doaj  

A rare association of Takotsubo cardiomyopathy with neuroleptic malignant syndrome

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2020
Neuroleptic malignant syndrome is a potentially fatal neurological condition secondary to antipsychotic medication. It is characterized by distinctive clinical findings and autonomic disturbances. NMS has not been associated with Takotsubo cardiomyopathy
Waqas Ullah   +6 more
doaj   +1 more source

Consensus document on palliative care in cardiorenal patients

open access: yesFrontiers in Cardiovascular Medicine, 2023
There is an unmet need to create consensus documents on the management of cardiorenal patients since, due to the aging of the population and the rise of both pathologies, these patients are becoming more prevalent in daily clinical practice.
Clara Bonanad   +25 more
doaj   +1 more source

Hearts, Data, and Artificial Intelligence Wizardry: From Imitation to Innovation in Cardiovascular Care

open access: yesBiomedicines
Artificial intelligence (AI) is transforming cardiovascular medicine by enabling the analysis of high-dimensional biomedical data with unprecedented precision.
Panteleimon Pantelidis   +11 more
doaj   +1 more source

Lifestyle Behaviors and Cardiotoxic Treatment Risks in Adult Childhood Cancer Survivors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Higher doses of anthracyclines and heart‐relevant radiotherapy increase cardiovascular disease (CVD) risk. This study assessed CVD and CVD risk factors among adult childhood cancer survivors (CCSs) across cardiotoxic treatment risk groups and examined associations between lifestyle behaviors and treatment risks.
Ruijie Li   +6 more
wiley   +1 more source

Transcatheter Mitral Valve Implantation: TMVI Status in 2024

open access: yesKardiyovasküler Tıp E Dergisi/E Journal of Cardiovascular Medicine
Today, it is almost 22 years since the first transcatheter aortic valve implant (TAVI) and 11 years since the first transcatheter mitral valve implantation (TMVI) was implanted. TMVI never escalated like TAVI. So far, only one transcatheter mitral valve (
Gry Dahle
doaj   +1 more source

Changes in Body Composition in Children and Young People Undergoing Treatment for Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Ongoing evidence indicates increased risk of sarcopenic obesity among children and young people (CYP) with acute lymphoblastic leukemia (ALL), often beginning early in treatment, persisting into survivorship. This review evaluates current literature on body composition in CYP with ALL during and after treatment.
Lina A. Zahed   +5 more
wiley   +1 more source

Cardiovascular medicine [PDF]

open access: yes, 2007
Abstract Ischemic heart disease (IHD), even though | in incidence, is still the most common cause of death worldwide. Encouraging cardiovascular health is not only about preventing IHD. The activities that are associated with improving cardiovascular health have many beneficial side effects as well.
openaire   +2 more sources

Extracellular vesicle R-Ras is a potential biomarker for human peripheral artery disease

open access: yesiScience
Summary: Human peripheral artery disease (PAD) is common and associated with amputation, heart attack, stroke, and death. Treatment options are limited by inadequate understanding of disease pathophysiology and lack of early detection strategies.
Xiaochao Wei   +5 more
doaj   +1 more source

Patient‐Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Despite their increased risk for functional impairment resulting from cancer and its treatments, few adolescents and young adults (AYAs) with a hematological malignancy receive the recommended or therapeutic dose of exercise per week during inpatient hospitalizations.
Jennifer A. Kelleher   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy